Tel: 01892 526726     Email:     Twitter

Broad and learned
clinical background

Gut Reactions #10 – New drug for Crohn’s disease receives UK licence

Ustekinumab is a drug designed to mimic normal human molecules, and for this reason is called a ‘biological’ drug. Results of a large well-conducted trial found that it is significantly better than placebo at inducing and maintaining remission in patients ...

Read more